Abigail Johnson — Form 4 insider transactions

Fidelity Management & Research (FMR) — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-11-10 Sell Avalyn Pharma Inc. 47,889 $30.28 $1,450,079 SEC filing
2026-11-10 Sell Avalyn Pharma Inc. 5,565 $29.56 $164,501 SEC filing
2026-11-09 Sell Avalyn Pharma Inc. 1,339 $29.75 $39,835 SEC filing
2026-11-09 Sell Avalyn Pharma Inc. 173,661 $29.06 $5,046,589 SEC filing
2026-06-26 Sell Beam Therapeutics Inc. 251,488 $35.26 $8,867,467 SEC filing
2026-06-25 Sell Beam Therapeutics Inc. 33,372 $35.12 $1,172,025 SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 377,948 — — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 225,843 — — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 872,868 — — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 80,291 — — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 727,585 — — SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions → · Manager overview